Paul Marshall, SVP, Technical Operations at HERON THERAPEUTICS, INC. /DE/ (HRTX), sold 70,000 shares at $14.40 ($1.0M) on 2015-03-05, disclosed to the SEC on 2015-03-09.
Scheduled sale ($1.0M) by SVP, Technical Operations under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.40 | 50,000 | $720K | 70.0% |
| 2 | $15.40 | 20,000 | $308K | 30.0% |
| Total | $14.69 avg | 70,000 | $1.0M | 100% |